Literature DB >> 26823454

Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs.

Ekaterina Petrovich1, Sara W Feigelson1, Liat Stoler-Barak1, Miki Hatzav1, Adam Solomon1, Amir Bar-Shai1, Neta Ilan2, Jin-Ping Li3, Britta Engelhardt4, Israel Vlodavsky2, Ronen Alon5.   

Abstract

The pulmonary vasculature constitutively expresses the integrin lymphocyte function-associated antigen-1 ligands intercellular adhesion molecule (ICAM)-1 and -2. In this study, effector T cells were temporarily entrapped by the lung vasculature on their way to inflamed lymph nodes, and this entrapment was strongly reduced in ICAM-1 and -2 double-deficient mice (79 and 86% reduction for CD8(+) and CD4(+) effectors, respectively, compared with wild-type mice). Although the pulmonary vasculature has been suggested to be masked by the heparan sulfate-containing glycocalyx, which is susceptible to heparanase-mediated shedding, lung and lymphocyte heparanase have been found to be unnecessary for this entrapment. Systemic LPS induced rapid neutrophil entrapment in the lung vasculature, but in contrast to T-cell entrapment, this sequestration was ICAM-1, ICAM-2, and heparanase independent. Furthermore, neutrophil migration into the bronchoalveolar space induced by LPS inhalation and LPS-induced leakage of red blood cells into this space were not dependent on lung ICAMs or heparanase activity. Nevertheless, heparanase was critical for neutrophil accumulation in smoke-exposed lungs. Our results indicate that, whereas T cells use ICAM-1 and -2 for temporary pulmonary entrapment, neutrophils get sequestered and extravasate into inflamed lungs independent of ICAMs. This is the first demonstration that the pulmonary vasculature is differentially recognized by T cells and neutrophils.-Petrovich, E., Feigelson, S. W., Stoler-Barak, L., Hatzav, M., Solomon, A., Bar-Shai, A., Ilan, N., Li, J.-P., Engelhardt, B., Vlodavsky, I., Alon, R. Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs. © FASEB.

Entities:  

Keywords:  heparan sulfate; heparanase; inflammation; β2 integrin

Mesh:

Substances:

Year:  2016        PMID: 26823454     DOI: 10.1096/fj.201500046

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Heparanase is required for activation and function of macrophages.

Authors:  Lilach Gutter-Kapon; Dror Alishekevitz; Yuval Shaked; Jin-Ping Li; Ami Aronheim; Neta Ilan; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 2.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

3.  ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.

Authors:  Ofer Regev; Marina Kizner; Francesco Roncato; Maya Dadiani; Massimo Saini; Francesc Castro-Giner; Olga Yajuk; Stav Kozlovski; Nehora Levi; Yoseph Addadi; Ofra Golani; Shifra Ben-Dor; Zvi Granot; Nicola Aceto; Ronen Alon
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 4.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

Review 5.  Multifaceted interactions between adaptive immunity and the central nervous system.

Authors:  Jonathan Kipnis
Journal:  Science       Date:  2016-08-19       Impact factor: 47.728

6.  The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target.

Authors:  Iyad Khamaysi; Preeti Singh; Susan Nasser; Hoda Awad; Yehuda Chowers; Edmond Sabo; Edward Hammond; Ian Gralnek; Irena Minkov; Alessandro Noseda; Neta Ilan; Israel Vlodavsky; Zaid Abassi
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

Review 7.  Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.

Authors:  Ronen Alon; Mike Sportiello; Stav Kozlovski; Ashwin Kumar; Emma C Reilly; Alexander Zarbock; Natalio Garbi; David J Topham
Journal:  Nat Rev Immunol       Date:  2020-11-19       Impact factor: 53.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.